SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) disclosed today that it has published a paper entitled: "A Clinical Report on the Safety of the Aethlon HemopurifierTM." The report details the landmark use of the HemopurifierTM in a human infectious disease study conducted at the Apollo Hospital in Delhi, India. The HemopurifierTM is a first-in-class device designed to fill the void in treating drug and vaccine resistant pathogens. The report is available online at: www.aethlonmedical.com/pdfs/ApolloHospitalSafetyStudy.pdf
